XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Income (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue $ 125,341 $ 153,616 $ 445,609 $ 513,045
Cost of revenue 60,065 35,858 137,790 109,933
Gross profit 65,276 117,758 307,819 403,112
Operating expenses:        
Research and development 6,905 5,312 12,894 10,734
Selling and marketing 10,866 5,219 18,806 10,227
General and administrative 30,240 8,329 56,015 16,331
Amortization of intangible assets 1,575   2,481  
Restructuring Costs 2,896   2,896  
Total operating expenses 52,482 18,860 93,092 37,292
Operating income 12,794 98,898 214,727 365,820
Interest and other income, net 958 604 1,003 886
Income before income taxes and gain on equity method investment 13,752 99,502 215,730 366,706
Provision for income taxes 2,653 23,589 51,074 90,102
Income before gain on equity method investment 11,099 75,913 164,656 276,604
Gain on equity method investment   3,734   3,734
Net income from consolidated operations 11,099 79,647 164,656 280,338
Net loss attributable to noncontrolling interests 438 165 860 165
Net income attributable to Fulgent $ 11,537 $ 79,812 $ 165,516 $ 280,503
Net income per common share attributable to Fulgent:        
Basic $ 0.38 $ 2.74 $ 5.46 $ 9.68
Diluted $ 0.37 $ 2.59 $ 5.30 $ 9.10
Weighted-average common shares:        
Basic 30,362 29,150 30,298 28,991
Diluted 31,189 30,830 31,225 30,809